has offered to pay $2.4 billion for Norway's Algeta , its partner for a new prostate cancer treatment, at a 27 percent premium to the stock's last close, Algeta said on Tuesday. The deal would boost Bayer's drugs division by giving it outright control over Xofigo, a drug the two have developed jointly since 2009 and started selling in the United States this year. Investors, however, bet that the German drugs and chemicals group has a fight on its hands and Algeta's Chief Financial Officer said that rival bids could not be ruled out.
via Health News Headlines - Yahoo! News http://news.yahoo.com/bayer-makes-2-4-billion-takeover-bid-norways-063418083--finance.html
No comments:
Post a Comment